belantamab mafodotin,allo-715,bms-986393,idecabtagene vicleucel
bms,gsk,allogene therapeutics,2seventy bio
['belantamab,mafodotin', 'bms-986393', 'belantamab', 'allo 715', 'idecabtagene', 'bms']
#ash2022
some good data for the myeloma treatments! hopefully the responses are durable. 
Biotech is a place for innovation - the stock market doesn’t understand